Brain+ ApS Total Assets
Brain+ ApS total assets. Based on the latest financial reports, Brain+ ApS (BRAINP) holds total assets worth Dkr35.35 Million DKK (≈ $5.53 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see BRAINP market cap for the company's overall valuation and market capitalisation.
Total Assets of Brain+ ApS (2015–2024)
Total assets of Brain+ ApS from 2015 to 2024. This chart illustrates how Brain+ ApS's total assets have evolved over time, based on quarterly financial data. See BRAINP share price today for real-time trading data and today's change.
Brain+ ApS - Asset Composition Analysis
Brain+ ApS Total Assets Breakdown (December 2024)
Brain+ ApS total assets breakdown as of December 2024. Brain+ ApS's total assets of Dkr35.35 Million consist of 2.5% current assets and 97.5% non-current assets.
| Asset Category | Amount (DKK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Dkr0.00 | 0.2% |
| Accounts Receivable | Dkr707.52K | 2.1% |
| Inventory | Dkr0.00 | 0.0% |
| Property, Plant & Equipment | Dkr0.00 | 0.0% |
| Intangible Assets | Dkr32.22 Million | 97.2% |
| Goodwill | Dkr0.00 | 0.0% |
Asset Composition Trend (2015–2024)
This chart illustrates how Brain+ ApS's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Brain+ ApS (BRAINP) liquidity to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Brain+ ApS's current assets represent 2.5% of total assets in 2024, a decrease from 21.0% in 2015.
- Cash Position: Cash and equivalents constituted 0.2% of total assets in 2024, down from 4.8% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 97.0% of total assets, an increase from 78.0% in 2015.
- Asset Diversification: The largest asset category is intangible assets at 97.2% of total assets.
Brain+ ApS Competitors by Total Assets
Key competitors of Brain+ ApS based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Reliq Health Technologies Inc
V:RHT
|
Canada | CA$22.29 Million |
|
Newtopia Inc
V:NEWU
|
Canada | CA$664.83K |
|
Feedback PLC
LSE:FDBK
|
UK | GBX4.86 Million |
|
Pro Medicus Ltd
AU:PME
|
Australia | AU$610.14 Million |
|
Cogstate Ltd
AU:CGS
|
Australia | AU$64.77 Million |
|
ARTRYA Ltd
AU:AYA
|
Australia | AU$92.19 Million |
|
Echoiq Ltd
AU:EIQ
|
Australia | AU$17.99 Million |
|
Alcidion Group Ltd
AU:ALC
|
Australia | AU$115.63 Million |
Brain+ ApS - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.80 | 1.40 | 0.25 |
| Quick Ratio | 1.80 | 1.40 | 0.25 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Dkr2.26 Million | Dkr1.79 Million | Dkr-19.24 Million |
Brain+ ApS - Advanced Valuation Insights
This section examines the relationship between Brain+ ApS's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.28 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | -7.9% |
| Total Assets | Dkr33.13 Million |
| Market Capitalization | $744.48K USD |
Valuation Analysis
Below Book Valuation: The market values Brain+ ApS's assets below their book value (0.02x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Brain+ ApS's assets decreased by 7.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Brain+ ApS (2015–2024)
The table below shows the annual total assets of Brain+ ApS from 2015 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Dkr33.13 Million ≈ $5.18 Million |
-7.88% |
| 2023-12-31 | Dkr35.97 Million ≈ $5.63 Million |
-20.72% |
| 2022-12-31 | Dkr45.37 Million ≈ $7.10 Million |
-3.22% |
| 2021-12-31 | Dkr46.88 Million ≈ $7.34 Million |
+56.86% |
| 2020-12-31 | Dkr29.89 Million ≈ $4.68 Million |
+25.53% |
| 2019-12-31 | Dkr23.81 Million ≈ $3.73 Million |
+4.57% |
| 2018-12-31 | Dkr22.77 Million ≈ $3.56 Million |
+40.14% |
| 2017-12-31 | Dkr16.25 Million ≈ $2.54 Million |
+45.76% |
| 2016-12-31 | Dkr11.15 Million ≈ $1.74 Million |
+22.25% |
| 2015-12-31 | Dkr9.12 Million ≈ $1.43 Million |
-- |
About Brain+ ApS
Brain+ A/S, a healthtech company, develops and commercializes technology solutions in dementia care primarily for cognitive stimulation therapy. The company is developing Ayla, a scalable dementia care platform that offers practical, human-centered, and clinically proven software-based dementia therapy and care solutions. It is also developing Ayla " your CST Assistant, a software-based dementia … Read more